Hiding the numbers of dead fish behind claims of commercial disadvantage is unacceptable
Along the Derwent River in Tasmania, a temperature-driven bacterial outbreak at a salmon hatchery prompted the use of tens of kilograms of a World Health Organization-flagged antibiotic — and what followed was not merely a contamination event, but a revelation of how regulatory frameworks can lag behind the realities they are meant to govern. Residues of oxytetracycline spread into water, sediment, and eels downstream, while mandatory monitoring and disclosure requirements for freshwater hatcheries did not exist to catch it in time. The episode asks an enduring question about the commons: when a private enterprise draws from a shared river and returns something the community did not consent to, who is accountable, and to whom?
- A five-degree temperature spike in January triggered a bacterial crisis at Huon Aquaculture's Meadowbank hatchery, prompting the rapid deployment of nearly 52 kilograms of oxytetracycline — a drug the WHO has linked to antibiotic resistance when overused in food production.
- Downstream sampling revealed the antibiotic had dispersed widely: one water reading came in at fifty times the reporting threshold, sediment levels remained dangerously elevated for three months, and three eels tested positive for residues.
- Regulatory gaps compounded the contamination — freshwater hatcheries face no mandatory antibiotic reporting requirements, the EPA's monitoring schedule wasn't finalised until two days after treatment began, and the public wasn't informed for more than two weeks.
- A promise made in January to introduce new monitoring standards for all freshwater hatcheries by the end of March has gone unfulfilled, with no firm deadline in sight and independent MP Meg Webb demanding a public explanation for the delay.
- Huon Aquaculture's refusal to disclose fish mortality figures — sheltered behind claims of commercial sensitivity — has sharpened the central tension: a private company using a public waterway, operating under rules that were not built to catch what it left behind.
In January, a sudden five-degree rise in river water temperature set off a bacterial infection inside the salmon tanks at Huon Aquaculture's Meadowbank hatchery on the Derwent River. The company responded quickly, administering nearly 52 kilograms of oxytetracycline — an antibiotic the World Health Organization has identified as a contributor to drug-resistant superbugs when overused in food production. The disease was brought under control. What remained in the river became the story.
Eight weeks of downstream sampling by a consultant hired by Huon found OTC residues in water, sediment, and eels. A water sample collected 500 metres downstream just six days into treatment measured fifty times the reporting threshold. Sediment in the effluent sludge tank peaked at 1800 milligrams per kilogram and stayed well above acceptable limits for three months. Three short-finned eels tested positive, with the highest concentration at five times the limit — though still below the threshold for human consumption.
The contamination was serious. The regulatory vacuum around it was arguably more so. Freshwater salmon hatcheries in Tasmania carry no obligation to monitor or report antibiotic use. Huon voluntarily told the Environment Protection Authority about the treatment, but both the company and the regulator withheld the information for over two weeks until a journalist asked questions. The EPA's monitoring schedule wasn't even finalised until two days after treatment had already begun, meaning the earliest sediment samples missed the contamination's peak.
Independent MP Meg Webb, who chaired a 2020 inquiry into finfish farming, has called the response inadequate. In January, the EPA promised that new antibiotic residue monitoring requirements would apply to all freshwater hatcheries by the end of March. Months on, those standards remain unfinished. Webb is pushing for mandatory antibiotic disclosure and monitoring to be embedded in licensing conditions, and is demanding the EPA explain why it has taken close to six months without delivering on its own commitment.
Huon has declined to reveal how many fish died during the outbreak, citing commercial sensitivity. Webb has rejected that reasoning outright: the hatchery draws from a public river, and the community has a right to know what is happening in it. The episode has laid bare a structural tension — a private operation using shared natural resources, treating disease with a globally significant drug, inside a regulatory system that was not designed to see it coming.
In January, a salmon hatchery on the Derwent River faced a crisis. A five-degree spike in water temperature drawn from the river triggered a bacterial infection in the fish tanks at Huon Aquaculture's Meadowbank facility. The company's response was swift: nearly 52 kilograms of oxytetracycline, an antibiotic the World Health Organization has flagged as a driver of drug-resistant superbugs when overused in food production. The treatment worked on the disease. What it left behind is now the subject of urgent scrutiny.
The antibiotic residues turned up everywhere downstream. Eight weeks of sampling by Marine Solutions Tasmania, a consultant hired by Huon, revealed OTC in sediments, water, and eels collected from the Derwent River ecosystem. The numbers tell the story of how thoroughly the drug dispersed. One water sample taken 500 metres downstream of the hatchery, collected just six days after antibiotic use began, measured 0.5 micrograms per litre—fifty times the reporting threshold. Sediment in the effluent sludge tank peaked at 1800 milligrams per kilogram, a reading that stayed well above acceptable limits for three months. Even in early May, sediment at the discharge point remained six times higher than the threshold. Three short-finned eels tested positive, with the highest concentration at five times the limit, though still below the standard for human consumption.
What makes this discovery significant is not just the presence of the drug, but the absence of oversight. Freshwater salmon hatcheries in Tasmania are not required to monitor or report antibiotic use. Huon voluntarily disclosed its application to the Environment Protection Authority, but the company and the regulator kept the information private for more than two weeks until a journalist made inquiries. The EPA did not finalize its monitoring schedule until January 23—two days after Huon began treatment. This timing gap meant sediment samples from five river sites were not collected until six days after the first antibiotic dose, missing the peak of the contamination.
Meg Webb, an independent member of the Tasmanian Legislative Council and chair of a 2020 inquiry into finfish farming, has called the regulatory response inadequate. She points to a promise the EPA made in January: new monitoring requirements for antibiotic residues would apply to all freshwater hatcheries by the end of March. Months later, those standards remain under development with no firm deadline. Webb argues that full disclosure of antibiotic use and subsequent monitoring data must become a licensing requirement. "If the EPA has failed to put that in place close to six months after the Huon incident, the community deserves an explanation for the delay," she said. Sheenagh Neill, a spokesperson for Marine Protection Tasmania, was sharper in her criticism: "This report shows that once again the EPA has been caught unawares and left scrambling to try and catch up with antibiotic pollution of a major river by a salmon company."
Another question remains unanswered: how many fish died in the outbreak? Huon has refused to disclose the number, citing commercial sensitivity and the two-year production cycle of the fish. Webb rejected this reasoning. The hatchery operates in public waterways and draws water from a river that belongs to the community. Hiding mortality figures behind claims of competitive disadvantage, she said, is unacceptable. The company maintains that antibiotic use, applied on veterinary advice, is essential to animal health and best practice. But the tension is clear: a private operation using a public resource, treating disease with a drug that poses a global health risk, while operating under regulatory frameworks that were not designed to catch what happened here until it was already in the river.
Notable Quotes
This report shows that once again the EPA has been caught unawares and left scrambling to try and catch up with antibiotic pollution of a major river by a salmon company.— Sheenagh Neill, Marine Protection Tasmania
Full disclosure of antibiotic use and subsequent monitoring data must be a licensing requirement for freshwater fisheries.— Meg Webb, independent member of the Tasmanian Legislative Council
The Hearth Conversation Another angle on the story
Why does it matter that the monitoring schedule came two days late?
Because the antibiotic was already in the system. The peak contamination in the sludge tank hit 1800 mg/kg—they missed sampling that window entirely at five sites. You can't measure what you don't collect.
But the residues were still found downstream. Doesn't that mean the monitoring worked?
It worked after the fact. The real issue is that there was no monitoring requirement in the first place. Huon reported voluntarily. If they hadn't, nobody would have known.
What's the actual health risk here? The eel samples were below the consumption standard.
The eels aren't the endpoint. They're an indicator. The concern is antibiotic-resistant bacteria developing in the river ecosystem itself—bacteria that could spread beyond the hatchery. The WHO has called that one of the biggest threats to global health.
So why hasn't the EPA implemented the new standards yet?
That's the question Webb is asking. They said March. It's now July. The agency was caught off guard and is still catching up.
Is Huon the only hatchery doing this?
No. There are ten flow-through freshwater hatcheries in Tasmania. None of them are required to monitor antibiotic use. This is the first time residues have been publicly documented, but it's likely not the first time it's happened.
What does Webb want to change?
Mandatory disclosure and monitoring as a licensing requirement. Right now it's voluntary. She also wants to know how many fish died—the company won't say, claiming commercial sensitivity. She thinks that's unacceptable when you're operating in public water.